Rationale of the Growth Failure in Children with Renal Diseases Study.

[1]  R. Morris,et al.  Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men. , 1989, The Journal of clinical investigation.

[2]  D. Roxe,et al.  Phosphate-binding effects of sucralfate in patients with chronic renal failure. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  J. Jellema.  HALLUCINATION DURING SUSTAINED-RELEASE MORPHINE AND METHADONE ADMINISTRATION , 1987, The Lancet.

[4]  A. Korkor.  Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure. , 1987, The New England journal of medicine.

[5]  James M. Tanner,et al.  Assessment of skeletal maturity and prediction of adult height : (TW2 method) , 1986 .

[6]  J. Russell,et al.  Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[7]  H. Harter,et al.  Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. , 1984, The Journal of clinical investigation.

[8]  R. B. Young,et al.  Hypercalcemia in children with disorders of calcium and phosphate metabolism during long-term treatment with 1,25-dihydroxyvitamin-D3. , 1983, Pediatrics.

[9]  S. Madsen,et al.  Suppressive effect of 1,25-dihydroxyvitamin D3 on circulating parathyroid hormone in acute renal failure. , 1981, The Journal of clinical endocrinology and metabolism.

[10]  M. Kodroff,et al.  Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure. , 1981, Pediatrics.

[11]  E. Spencer,et al.  The mechanism of the action of growth hormone on vitamin D metabolism in the rat. , 1981, Endocrinology.

[12]  D. G. Dale.  Monographs on Endocrinology , 1981 .

[13]  S. Massry,et al.  The duodenal mucosa in patients with renal failure: response to 1,25(OH)2D3. , 1981, Kidney international.

[14]  S. Massry,et al.  Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy. , 1980, Kidney international.

[15]  A. F. Lever,et al.  CAPTOPRIL OR FRUSEMIDE IN DRUG-RESISTANT HYPERTENSION? , 1980, The Lancet.

[16]  J. Chan,et al.  Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin-D3. , 1980, Pediatrics.

[17]  C. Fullmer,et al.  Effect to cholecalciferol and 1,25-Dihydroxycholecalciferol on the intestinal absorption of zinc in the chick. , 1980, The Journal of nutrition.

[18]  C. Chantler,et al.  Nutritional therapy in children with chronic renal failure. , 1980, The American journal of clinical nutrition.

[19]  C. Chantler,et al.  Oral essential amino acid supplements in children with advanced chronic renal failure. , 1980, The American journal of clinical nutrition.

[20]  J. Kopple,et al.  Methods for assessing nutritional status of patients with renal failure. , 1980, The American journal of clinical nutrition.

[21]  E. Slatopolsky,et al.  Use of a new phosphate binder in chronic renal insufficiency. , 1980, Kidney international.

[22]  J. Zerwekh,et al.  Effect of 1,25-(OH)2D3 on jejunal absorption of magnesium in patients with chronic renal disease. , 1980, The American journal of physiology.

[23]  F. Bartter,et al.  Hypophosphatemic Rickets: Effect of 1α, 25-Dihydroxyvitamin D3 on Growth and Mineral Metabolism , 1979, Pediatrics.

[24]  H. DeLuca.  Vitamin D metabolism and function. , 1979, Monographs on endocrinology.

[25]  S. Massry,et al.  Reversal of skeletal resistance to parathyroid hormone in uremia by vitamin D metabolites: evidence for the requirement of 1,25(OH)2D3 and 24,25(OH)2D3. , 1979, Journal of Laboratory and Clinical Medicine.

[26]  J. Chan,et al.  Calcium and parathyroid disorders in children. Chronic renal failure and treatment with calcitriol. , 1979, JAMA.

[27]  M. Scrutton.  Vitamin D: Biochemical, Chemical and Clinical Aspects related to Calcium Metabolism , 1979 .

[28]  J. Omdahl.  Interaction of the parathyroid and 1,25-dihydroxyvitamin D3 in the control of renal 25-hydroxyvitamin D3 metabolism. , 1978, The Journal of biological chemistry.

[29]  A. Ornoy,et al.  24, 25-Dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation , 1978, Nature.

[30]  J. Chan.  Late complications of long-term hemodialysis in children: clinical aspects and some measurable variables concerning parathyroid hormone, divalent ions, acid-base metabolism, anemia, nutrition, growth and survival data. , 1978, The Journal of urology.

[31]  A. Ashworth.  Energy balance and growth: experience in treating children with malnutrition. , 1978, Kidney international.

[32]  E. Ritz,et al.  Effect of vitamin D on growth in experimental uremia. , 1978, The American journal of clinical nutrition.

[33]  P. Fürst,et al.  Principles of essential amino acid therapy in uremia. , 1978, The American journal of clinical nutrition.

[34]  A. Roche.  Growth assessment in abnormal children. , 1978, Kidney international.

[35]  J. Kopple.  Abnormal amino acid and protein metabolism in uremia. , 1978, Kidney international.

[36]  C. Christiansen,et al.  DETERIORATION OF RENAL FUNCTION DURING TREATMENT OF CHRONIC RENAL FAILURE WITH 1,25- DIHYDROXYCHOLECALCIFEROL , 1978, The Lancet.

[37]  R. DeFronzo,et al.  Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. , 1978, The Journal of clinical investigation.

[38]  A. Garber,et al.  Abnormal carbohydrate metabolism in chronic renal failure. The potential role of accelerated glucose production, increased gluconeogenesis, and impaired glucose disposal. , 1978, The Journal of clinical investigation.

[39]  Leumann Ep.  Progression of renal insufficiency in pediatric patients: estimation from serum creatinine. , 1978 .

[40]  H. DeLuca,et al.  Increased growth after long-term oral 1alpha,25-vitamin D3 in childhood renal osteodystrophy. , 1978, The New England journal of medicine.

[41]  H. DeLuca,et al.  Growth Velocity in a Child on Prolonged Hemodialysis: Beneficial Effect of 1-α-Hydroxyvitamin D3 , 1977 .

[42]  J. C. Smith,et al.  REVERSAL OF URÆMIC IMPOTENCE BY ZINC , 1977, The Lancet.

[43]  Holliday Ma,et al.  Improved growth in growth retarded uremic rats with use of calorie supplementation. , 1977 .

[44]  H. DeLuca,et al.  Effectiveness of 1 alpha-hydroxyvitamin D3 in children with renal osteodystrophy associated with hemodialysis. , 1977, The Journal of pediatrics.

[45]  C. Chantler,et al.  Effect of uremia on nutritionally-induced variations in protein metabolism. , 1977, Kidney international.

[46]  W. Mitch,et al.  A SIMPLE METHOD OF ESTIMATING PROGRESSION OF CHRONIC RENAL FAILURE , 1976, The Lancet.

[47]  P. Betts,et al.  Growth and Nutrition of Uremic Piglets , 1976, Pediatric Research.

[48]  R. Edelman,et al.  Complement activity in children with protein-calorie malnutrition. , 1976, The American journal of clinical nutrition.

[49]  P. Payne,et al.  Energy balance during recovery from malnutrition. , 1976, The American journal of clinical nutrition.

[50]  J. Bröchner-Mortensen,et al.  Iatrogenic magnesium intoxication during 1-alpha-hydroxycholecalciferol treatment. , 1976, British medical journal.

[51]  M. Swendseid,et al.  Biochemical assessment of the nutritional status of low-income pregnant women of Mexican descent. , 1976, The American journal of clinical nutrition.

[52]  M. Christensen,et al.  CONTROLLED TRIAL OF 1α-HYDROXYCHOLECALCIFEROL IN CHRONIC RENAL FAILURE , 1976, The Lancet.

[53]  J. Tanner,et al.  Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. , 1976, Archives of disease in childhood.

[54]  H. DeLuca,et al.  1-alpha-hydroxyvitamin D3 in chronic renal failure. A potent analogue of the kidney hormone, 1,25-dihydroxycholecalciferol. , 1975, JAMA.

[55]  M. de Visscher,et al.  Albumin, transferrin and the thyroxine-binding prealbumin/retinol-binding protein (TBPA-RBP) complex in assessment of malnutrition. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[56]  A. Zerfas.  The insertion tape: a new circumference tape for use in nutritional assessment. , 1975, The American journal of clinical nutrition.

[57]  P. Betts,et al.  Growth Pattern and Dietary Intake of Children with Chronic Renal Insufficiency , 1974, British medical journal.

[58]  B. Roof,et al.  Parathyroid function in uremic children with and without osteodystrophy. , 1974, Pediatrics.

[59]  C. Chantler,et al.  A Rat Model for the Study of Growth Failure in Uremia , 1974, Pediatric Research.

[60]  J. Kopple,et al.  METABOLIC STUDIES OF LOW PROTEIN DIETS IN UREMIA: II. CALCIUM, PHOSPHOKUS AND MAGNESIUM , 1973, Medicine.

[61]  S. Birge,et al.  Stimulation of intestinal mucosal proliferation by vitamin D. , 1973, Gastroenterology.

[62]  A. Norman,et al.  Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man. , 1972, The New England journal of medicine.

[63]  A. Norman,et al.  Studies on the mechanism of action of calciferol. V. Turnover time of chick intestinal epithelial cells in relation to the intestinal action of vitamin D. , 1972, Experimental cell research.

[64]  L. Avioli.  Intestinal absorption of calcium. , 1972, Archives of internal medicine.

[65]  F. R. Smith,et al.  The effects of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma. , 1971, The Journal of clinical investigation.

[66]  M. Holliday,et al.  Relation of calorie deficiency to growth failure in children on hemodialysis and the growth response to calorie supplementation. , 1971, The New England journal of medicine.

[67]  D. Fraser,et al.  Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite , 1970, Nature.

[68]  H. Macfarlane,et al.  Biochemical assessment of protein-calorie malnutrition. , 1969, Lancet.

[69]  E. Clarkson,et al.  MAGNESIUM METABOLISM IN CHRONIC RENAL FAILURE. , 1965, Clinical science.

[70]  F. A. Schofield,et al.  Calcium, phosphorus and magnesium. , 1960, Federation proceedings.

[71]  E. Widdowson.  A Study of Individual Children's Diets , 1947 .

[72]  S. H. Liu,et al.  STUDIES OF CALCIUM AND PHOSPHORUS METABOLISM WITH SPECIAL REFERENCE TO PATHOGENESIS AND EFFECTS OF DIHYDROTACHYSTEROL (A.T.10) AND IRON , 1943 .

[73]  W. Mitch,et al.  Nutrition in Renal Disease , 1987 .

[74]  J. Chan.  Clinical Disorders of Calcium Metabolism in Chronic Renal Failure in Children , 1981 .

[75]  H. DeLuca,et al.  Influence of Long-Term Oral 1,25-Dihydroxyvitamin D in Childhood Renal Osteodystrophy1 , 1980 .

[76]  J. Winchester,et al.  Controversies in nephrology , 1979 .

[77]  J. Kanis,et al.  The biological effects of 1, 24, 25-Trihydroxyvitamin D3 in man , 1979 .

[78]  Jones Mr.,et al.  Amino acid metabolism in patients with advanced uremia and in patients undergoing chronic dialysis. , 1979 .

[79]  P. Fürst,et al.  Intracellular free amino acids in muscle tissue of patients with chronic uraemia: effect of peritoneal dialysis and infusion of essential amino acids. , 1978, Clinical science and molecular medicine.

[80]  J. Miller,et al.  Chronic progressive renal disease: rate of change of serum creatinine concentration. , 1977, Kidney international.

[81]  C. Abitbol,et al.  Total parenteral nutrition in anuric children. , 1976, Clinical nephrology.

[82]  C. Ogg,et al.  Plasma amino acids in children and adolescents on hemodialysis. , 1976, Kidney international.

[83]  Kopple Jd,et al.  Protein and amino acid metabolism in uremic patients undergoing maintenance hemodialysis. , 1975 .

[84]  Y. Ingenbleek.  Albumin, transferrin and the thyroxine-binding prealbumin/retinol binding protein complex in assessment of malnutrition , 1975 .

[85]  E. N. Wardle,et al.  Serum proteins as indicators of poor dietary intake in patients with chronic renal failure. , 1975, Clinical nephrology.

[86]  W. Anthony,et al.  1,25-Dihydroxycholecalciferol--a hormonally active form of vitamin D. , 1974 .

[87]  E. Freis,et al.  Letter: Rauwolfia derivatives and cancer. , 1974, Lancet.

[88]  M. Black.  Letter: Cryostat sections in immunological studies of cancer. , 1973, Lancet.